Document is current
Any future updates will be listed below
-
Authors
Karimi-Mostowfi, Nicki https://orcid.org/0009-0009-7607-2186
Chu, Fang-I https://orcid.org/0000-0003-2292-3079
Wu, Trudy C. https://orcid.org/0000-0002-9475-2072
Farrell, Matthew J. https://orcid.org/0000-0003-4810-6253
Akingbemi, Wisdom
Raldow, Ann C. https://orcid.org/0000-0001-8996-6810
-
Funding
Funding for this research was provided by:
UCLA Radiation Oncology Medical Student Preceptorship Program
- License Information
-
More Information
Article History
Received: 13 December 2023
Accepted: 14 March 2025
First Online: 26 March 2025
Declarations
:
: This is a cohort study. No ethical approval is required.
: Individuals who participate in the MHOS survey provided informed consent. SEER-MHOS linked data are limited datasets exempt from additional requirements of obtaining informed consent by the Health Insurance Portability and Accountability Act (HIPAA) of 1996. This act mandates that investigators sign a Data Usage Agreement (DUA) to the National Cancer Institute (NCI) for approval prior to receiving any data, which allows the release of the SEER-MHOS data without authorization from survey respondents.
: Author Dr. Ann Raldow receives grants and/or consulting/speaker fees from Intelligent Automation Inc, Clarity PSO/RO-ILS, ViewRay, and California Technology Assessment Forum, outside the submitted work. No further authors have any relevant financial or non-financial interests to disclose.
